Additionally, the AD dementia group had increased GFAP, p-tau181, and NfL levels relative to the CU A+T−, CU A+T+, and MCI+ groups, as well as decreased Aβ42/Aβ40 levels relative to the CU A+T− and MCI+ groups. This evidence concerns the gene NEFL and Alzheimer disease.